FREMONT, Calif., March 25, 2019 (GLOBE NEWSWIRE) — SpineEX, Inc., a medical device company focused on the design, development and marketing of products for spine disorders, received an additional U.S. Food and Drug Administration (FDA) clearance for its innovative Sagittae Lateral Lumbar Interbody (LLIF) Fusion System.  This additional 510(k) clearance will enhance SpineEX’s ability to …